Helps healthcare professionals navigate the maze of information and disinformation about medical cannabis Written for all healthcare professionals who are considering including medical cannabis in their treatment plans, this is the first handbook to disseminate all the information needed to advise patients safely and legally. Replete with evidence-based guidelines firmly grounded in the most up-to-date research, this resource covers the historical, legal, and biological context of medical cannabis so healthcare professionals can confidently discuss possible plans with their patients. Medical…mehr
Helps healthcare professionals navigate the maze of information and disinformation about medical cannabis Written for all healthcare professionals who are considering including medical cannabis in their treatment plans, this is the first handbook to disseminate all the information needed to advise patients safely and legally. Replete with evidence-based guidelines firmly grounded in the most up-to-date research, this resource covers the historical, legal, and biological context of medical cannabis so healthcare professionals can confidently discuss possible plans with their patients. Medical Cannabis Handbook For Healthcare Professionals delves into the biology of the endocannabinoid system, addressing how cannabis interacts with the body, its effects and side effects, and how to manage cannabis-drug interactions. Chapters discuss in detail how to talk to patients, what language providers can and cannot use, protocols for patient-centered dosing, and the variety of available cannabinoid pharmaceuticals. Based on the latest research, this book demonstrates the efficacy of cannabis in treating a broad range of symptoms and conditions. Written for any healthcare professional who might have to answer patient questions about medical cannabis, this handbook dispels common myths and confirms little-known facts about medical cannabis. KEY FEATURES: * Delivers the most up-to-date, evidence-based research on medical cannabis to enhance understanding of this complex topic * Provides historical, legal, and biological content so that healthcare professionals can confidently discuss medical cannabis with patients * Dispels common cannabis myths and misinformation * Discusses pain management regarding cannabis and opioids * Co-published with Medical Marijuana 411, the leading medical cannabis education provider to offer online CME, CPE, and CNE courses to health professionals worldwide; and required certifications for dispensary consultantsHinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Foreword by Jack Cox, MD, MMM Acknowledgments Legal Landscape An Ancient Plant for Modern Illnesses The Discovery of the Endocannabinoid System The Endocannabinoid System Cannabinoids and Terpenes Cannabinoid Pharmaceuticals Getting Cannabinoids Into The Bloodstream Patient Centered Dosing Laboratory Testing Clinical Practice Cannabis and Opioids Side Effects Of Cannabis Use Medical Marijuana Myths And Facts Glossary of Terms Index OVERVIEW OF CHAPTERS CHAPTER 1: LEGAL LANDSCAPE This introductory chapter is intended to enable medical professionals to better understand the legal terrain of medical cannabis. It provides clinicians with an overview from a legal perspective of relevant medical cannabis regulations and what clinicians may and may not do when discussing cannabis in the context of a patient visit. CHAPTER 2: AN ANCIENT PLANT FOR MODERN ILLNESSES This chapter charts the development and spread of cannabis and its various uses as a fiber, as a food, and as a medicine as far back as 5,000 years ago. Cannabis was an essential treatment for the ancient Chinese, the Indian Ayurvedics, as well as the Victorians who adopted it into the Western Pharmacopoeia in the mid-1850s. It was used in Europe and North America as a household tonic until its prohibition in 1937 in the United States. CHAPTER 3: THE DISCOVERY OF THE ENDOCANNABINOID SYSTEM This chapter charts how the 1964 discovery of tetrahydrocannabinol (THC) and cannabidiol (CBD) led to the 1988 discovery of the Endocannabinoid System (ECS), the largest receptor system and the master regulator of homeostasis in the human body. This chapter also discusses how and why cannabinoids (endogenous and external) interact with CB1 and CB2 receptors to treat a vast number of illnesses. CHAPTER 4: THE ENDOCANNABINOID SYSTEM The Endocannabinoid System is deeply involved in maintaining homeostasis, neuroprotection, and other regulatory functions, many of which have yet to be discovered. It consists of endocannabinoids produced by the brain and a network of cannabinoid receptors located throughout the body. This chapter will provide an overview of how this system functions and how it is involved in so many disease states. CHAPTER 5: CANNABINOIDS AND TERPENES This chapter discusses endogenous and exogenous cannabinoids and the mechanisms through which they interact with the vast network of receptors in the Endocannabinoid System (ECS). It also discusses some of the other cannabinoids and terpenes naturally occurring in cannabis and the differences between treating with botanical medicines versus single molecule compounds. CHAPTER 6: CANNABINOID PHARMACEUTICALS This chapter is an educational overview listing the research, intended use, and availability of all FDA approved cannabinoid medications in the U.S. today. It is a resource for medical professionals who may prescribe these FDA-approved cannabinoids or who are assisting patients that are currently taking these cannabinoids as part of their prescribed treatment plan. CHAPTER 7: GETTING CANNABINOIDS INTO THE BLOODSTREAM This chapter familiarizes medical professionals with the many methods of delivering cannabinoids into the bloodstream - inhalation, oral mucosal absorption, edibles, and topicals - plus the advantages and disadvantages of each. Included are written and visual descriptions of all of forms of medical cannabis that a patient might encounter in a dispensary, plus the instruments that deliver them. This section also includes guides to onset times, duration of effects, and bioavailability with each method. CHAPTER 8: PATIENT CENTERED DOSING This chapter gives medical professionals a method of assisting patients to self-administer consistent, measurable doses of a cannabis remedy that includes as much THC as the patient is comfortable taking. It also includes the latest research on drug-drug interactions and spells out the patients for whom cannabis is a relative contraindication. CHAPTER 9: LABORATORY TESTING This chapter familiarizes medical professionals with the most accurate methods of identifying the cannabinoid profiles of a plant and ensuring the product is free of contaminants and safe for patient use. It includes an overview of testing methods and a guide to interpreting laboratory results. CHAPTER 10: CLINICAL PRACTICE Over a half dozen countries are planning to institute legal medical cannabis programs by 2020. This chapter provides an overview of some of the illnesses cannabis is being used to treat. They include certain cancers, anxiety, pain, epilepsy, insomnia, GI disorders, neurodegenerative illnesses, post traumatic stress, and migraines. CHAPTER 11: CANNABIS AND OPIOIDS The opioid crisis in America is worsening daily with addiction rates and the associated costs of addiction soaring. Counter to its ill-founded reputation as a "gateway drug," cannabis is proving to be more of a "terminus drug" that can increase the analgesic effects of opioid medications and also help patients cut their dosages. CHAPTER 12: SIDE EFFECTS OF CANNABIS USE This chapter discusses the adverse side effects of marijuana and marijuana products. It also discusses the risks of developing chronic conditions such as Cannabinoid Hyperemesis Syndrome and marijuana use disorder. CHAPTER 13: MEDICAL MARIJUANA MYTHS AND FACTS The history of marijuana research and science is littered with many fictions masquerading as facts. Now that you are aware of the latest science and methodologies of administering medical cannabis, it is important to review some of those myths to understand where they originated, how they have been perpetuated, and where the science-based truth lies.
Foreword by Jack Cox, MD, MMM Acknowledgments Legal Landscape An Ancient Plant for Modern Illnesses The Discovery of the Endocannabinoid System The Endocannabinoid System Cannabinoids and Terpenes Cannabinoid Pharmaceuticals Getting Cannabinoids Into The Bloodstream Patient Centered Dosing Laboratory Testing Clinical Practice Cannabis and Opioids Side Effects Of Cannabis Use Medical Marijuana Myths And Facts Glossary of Terms Index OVERVIEW OF CHAPTERS CHAPTER 1: LEGAL LANDSCAPE This introductory chapter is intended to enable medical professionals to better understand the legal terrain of medical cannabis. It provides clinicians with an overview from a legal perspective of relevant medical cannabis regulations and what clinicians may and may not do when discussing cannabis in the context of a patient visit. CHAPTER 2: AN ANCIENT PLANT FOR MODERN ILLNESSES This chapter charts the development and spread of cannabis and its various uses as a fiber, as a food, and as a medicine as far back as 5,000 years ago. Cannabis was an essential treatment for the ancient Chinese, the Indian Ayurvedics, as well as the Victorians who adopted it into the Western Pharmacopoeia in the mid-1850s. It was used in Europe and North America as a household tonic until its prohibition in 1937 in the United States. CHAPTER 3: THE DISCOVERY OF THE ENDOCANNABINOID SYSTEM This chapter charts how the 1964 discovery of tetrahydrocannabinol (THC) and cannabidiol (CBD) led to the 1988 discovery of the Endocannabinoid System (ECS), the largest receptor system and the master regulator of homeostasis in the human body. This chapter also discusses how and why cannabinoids (endogenous and external) interact with CB1 and CB2 receptors to treat a vast number of illnesses. CHAPTER 4: THE ENDOCANNABINOID SYSTEM The Endocannabinoid System is deeply involved in maintaining homeostasis, neuroprotection, and other regulatory functions, many of which have yet to be discovered. It consists of endocannabinoids produced by the brain and a network of cannabinoid receptors located throughout the body. This chapter will provide an overview of how this system functions and how it is involved in so many disease states. CHAPTER 5: CANNABINOIDS AND TERPENES This chapter discusses endogenous and exogenous cannabinoids and the mechanisms through which they interact with the vast network of receptors in the Endocannabinoid System (ECS). It also discusses some of the other cannabinoids and terpenes naturally occurring in cannabis and the differences between treating with botanical medicines versus single molecule compounds. CHAPTER 6: CANNABINOID PHARMACEUTICALS This chapter is an educational overview listing the research, intended use, and availability of all FDA approved cannabinoid medications in the U.S. today. It is a resource for medical professionals who may prescribe these FDA-approved cannabinoids or who are assisting patients that are currently taking these cannabinoids as part of their prescribed treatment plan. CHAPTER 7: GETTING CANNABINOIDS INTO THE BLOODSTREAM This chapter familiarizes medical professionals with the many methods of delivering cannabinoids into the bloodstream - inhalation, oral mucosal absorption, edibles, and topicals - plus the advantages and disadvantages of each. Included are written and visual descriptions of all of forms of medical cannabis that a patient might encounter in a dispensary, plus the instruments that deliver them. This section also includes guides to onset times, duration of effects, and bioavailability with each method. CHAPTER 8: PATIENT CENTERED DOSING This chapter gives medical professionals a method of assisting patients to self-administer consistent, measurable doses of a cannabis remedy that includes as much THC as the patient is comfortable taking. It also includes the latest research on drug-drug interactions and spells out the patients for whom cannabis is a relative contraindication. CHAPTER 9: LABORATORY TESTING This chapter familiarizes medical professionals with the most accurate methods of identifying the cannabinoid profiles of a plant and ensuring the product is free of contaminants and safe for patient use. It includes an overview of testing methods and a guide to interpreting laboratory results. CHAPTER 10: CLINICAL PRACTICE Over a half dozen countries are planning to institute legal medical cannabis programs by 2020. This chapter provides an overview of some of the illnesses cannabis is being used to treat. They include certain cancers, anxiety, pain, epilepsy, insomnia, GI disorders, neurodegenerative illnesses, post traumatic stress, and migraines. CHAPTER 11: CANNABIS AND OPIOIDS The opioid crisis in America is worsening daily with addiction rates and the associated costs of addiction soaring. Counter to its ill-founded reputation as a "gateway drug," cannabis is proving to be more of a "terminus drug" that can increase the analgesic effects of opioid medications and also help patients cut their dosages. CHAPTER 12: SIDE EFFECTS OF CANNABIS USE This chapter discusses the adverse side effects of marijuana and marijuana products. It also discusses the risks of developing chronic conditions such as Cannabinoid Hyperemesis Syndrome and marijuana use disorder. CHAPTER 13: MEDICAL MARIJUANA MYTHS AND FACTS The history of marijuana research and science is littered with many fictions masquerading as facts. Now that you are aware of the latest science and methodologies of administering medical cannabis, it is important to review some of those myths to understand where they originated, how they have been perpetuated, and where the science-based truth lies.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/neu
